Worldwide approved gene therapies based on viral vectors
Viral vectored gene therapies approved at a glance
In this infographic, you can discover the places where viral vector-based gene therapies have been approved so far. You will also find relevant information* about each of these treatments, such as the indication, the viral vector’s name, the therapeutic field, and the price established for each country/region.
Today there are 17 gene therapy products available on the market, not a lot some might say – but really impressive if you consider the challenges that had to be overcome to bring them to market. Exothera’s mission is to contribute to bringing the next products to market, with efficient and robust processes to make these products available to as many patients as possible.
* Sources: Alliance for Regenerative Medicine and originators’ websites